Adherence to statin treatment in people with type 1 and type 2 diabetes

被引:0
|
作者
Donnan, P. T. [1 ]
Donnelly, L. [1 ]
Morris, A. [1 ]
机构
[1] Univ Dundee, Dundee, Scotland
关键词
D O I
10.1016/S1098-3015(10)63308-6
中图分类号
F [经济];
学科分类号
02 ;
摘要
引用
收藏
页码:A236 / A236
页数:1
相关论文
共 50 条
  • [21] ADHERENCE TO INITIATED BASAL INSULIN ANALOG TREATMENT IN TYPE 1 AND 2 DIABETES
    Westerbacka, J.
    Mihailov, H.
    Valle, T.
    Jaaskelainen, S.
    Kaukua, J.
    VALUE IN HEALTH, 2015, 18 (07) : A612 - A612
  • [22] Adherence to initiated basal insulin analogue treatment in type 1 and 2 diabetes
    Westerbacka, J.
    Mihailov, H.
    Valle, T.
    Jaaskelainen, S.
    Kaukua, J.
    DIABETOLOGIA, 2015, 58 : S469 - S470
  • [23] Does a cardiovascular event change adherence to statin treatment in patients with type 2 diabetes? A matched cohort design
    de Vries, F. M.
    Denig, P.
    Vegter, S.
    Bos, H. J.
    Postma, M. J.
    Hak, E.
    CURRENT MEDICAL RESEARCH AND OPINION, 2015, 31 (04) : 595 - 602
  • [24] Validation of an abbreviated adherence measure for young people with Type 1 diabetes
    Markowitz, J. T.
    Laffel, L. M. B.
    Volkening, L. K.
    Anderson, B. J.
    Nansel, T. R.
    Weissberg-Benchell, J.
    Wysocki, T.
    DIABETIC MEDICINE, 2011, 28 (09) : 1113 - 1117
  • [25] Medical Utilization and Costs Associated with Statin Adherence in Medicaid Enrollees with Type 2 Diabetes
    Wu, Jun
    Seiber, Eric
    Lacombe, Veronique A.
    Nahata, Milap C.
    Balkrishnan, Rajesh
    ANNALS OF PHARMACOTHERAPY, 2011, 45 (03) : 342 - 349
  • [26] Holistic psychosocial determinants of adherence to medication in people with type 2 diabetes
    Reach, G.
    Pellan, M.
    Crine, A.
    Touboul, C.
    Ciocca, A.
    Djoudi, Y.
    DIABETES & METABOLISM, 2018, 44 (06) : 500 - 507
  • [27] Novel Psychosocial Determinants of Adherence to Medication in People with Type 2 Diabetes
    Reach, Gerard
    Crine, Amandine
    Touboul, Chantal
    Ciocca, Alice
    Le Douarin, Yann Mael
    Djoudi, Yasmina
    DIABETES, 2017, 66 : A220 - A220
  • [28] STATIN TREATMENT IN TYPE 1 DIABETES IS NOT ASSOCIATED WITH DIABETIC PERIPHERAL NEUROPATHY
    Pasha, Raabya
    Linn, Zara
    Kalteniece, Alise
    Bashir, Bilal
    Kamath, Anoushka
    Kolakaluri, Eirene
    Baptist, Mariamma
    Azmi, Shazli
    Ferdousi, Maryam
    Malik, Rayaz
    Soran, Handrean
    ATHEROSCLEROSIS PLUS, 2024, 57 : 9 - 9
  • [29] Glycemic treatment in type 1 and type 2 diabetes
    Bloomgarden, Zachary T.
    DIABETES CARE, 2006, 29 (11) : 2549 - 2555
  • [30] Exubera® -: Treatment of type 1 and type 2 diabetes
    Cox, SL
    DRUGS OF THE FUTURE, 2004, 29 (12) : 1206 - 1210